Implementing TruSight® Tumor 15 (TST15) for solid tumor profiling

Implementing TruSight Tumor 15 (TST15) for solid tumor profiling

Dr. Eike von Leitner and Prithwish Pal, PhD
Topic: Cancer Research

To gain efficiency in the lab, multigene testing is rapidly being adopted for tumor profiling. TruSight Tumor 15 (TST15) is a next-generation sequencing (NGS)-based assay which includes the 15 most common cancer biomarkers, and delivers a streamlined solution for multigene testing.

Join the webinar to find out about:

  • Results of the multicenter validation study on TruSight Tumor 15 across European pathology labs
  • Dr. von Leitner's perspective on the choice to adopt TruSight Tumor 15 and the steps involved for implementation at her laboratory in Hamburg
  • Upcoming software update supporting amplification analysis for the three critical genes (ERBB2, EGFR & MET), as well as support for automated library prep. 


American Society of Clinical Oncology (ASCO) Annual Meeting 2019
Chicago, IL | North America
Topic: Cancer Genomics
Cancer Genomics Consortium (CGC) Annual Meeting 2019
Nashville, TN | North America
Topic: Cancer Genomics
CHI Next Generation Dx Summit 2019
Washington, DC | North America
Topic: Cancer Genomics